Protagonist Therapeutics
Price & Volume
Stats
See moreOpen | $105.99 |
Previous Close | $105.40 |
Day Range | $104.12-$107.56 |
52W Range | $39.60-$105.99 |
Market Cap | $6.3B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $46M |
Revenue Growth (YoY) | -95.6% |
Gross Profit (12 Mos) | $46M |
Diluted EPS | -$2.05 |
News
See moreYahoo Finance • 5 days ago
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Yahoo Finance • 6 days ago
Do Protagonist Therapeutics’ (PTGX) Derisked Drugs Have Blockbuster Potential?
Yahoo Finance • 8 days ago
US High Growth Tech Stocks to Watch Now
Yahoo Finance • 11 days ago
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
About
CEO | Dr. Dinesh V. Patel Ph.D. |
CFO | Mr. Asif Ali |
Address | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 132 |
